Abstract Search

ea0049ep9 | Adrenal cortex (to include Cushing's) | ECE2017

Severe hypertriglyceridemia in relation to toxic levels of mitotane in a patient with stage IV adrenocortical carcinoma (ACC)

Larumbe Terroba , Soto Crespo , Goyogana Anacabe , De Linares Urbon Lopez , Sesmero Amon , Vina Ventosa , Olmedo Cuellar , Garcia Marcos , Roussel Otero , Munoz Almendros

Introduction: The use of mitotane as ACC therapy is associated with multiple adverse effects including hypercholesterolemia due to increased levels of LDL cholesterol. There are no reported cases of severe hypertriglyceridemia (HTG).Clinical case: A 59-year-old male with a personal history of dyslipidemia phenotype IV and pulmonary emphysema, former smoker and drinker was diagnosed with non-functioning left-sided ACC. Left adrenalectomy + left nephrectom...

0 shares

Endocrine Abstracts

Severe hypertriglyceridemia in relation to toxic levels of mitotane in a patient with stage IV adrenocortical carcinoma (ACC)

BiosciAbstracts